Mindy C Kohlhagen
Overview
Explore the profile of Mindy C Kohlhagen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ham H, Isham C, Ristagno E, Correia C, Ennis S, Kandasamy R, et al.
J Allergy Clin Immunol
. 2025 Mar;
PMID: 40072380
Background: The few reported patients with pathogenic IRF8 variants have manifested 2 distinct phenotypes: (1) an autosomal recessive severe immunodeficiency with significant neutrophilia and absence of or significant decrease in...
2.
Kanack A, Schaefer J, Sridharan M, Splinter N, Kohlhagen M, Singh B, et al.
Blood
. 2023 Jan;
141(14):1772-1776.
PMID: 36626584
No abstract available.
3.
Baloda V, Wheeler S, Murray D, Kohlhagen M, Vos J, Yatsenko S, et al.
Diagn Pathol
. 2022 Oct;
17(1):84.
PMID: 36266677
No abstract available.
4.
Miller I, Kohlhagen M, Ladwig P, Dasari S, Kumar S, Dispenzieri A, et al.
Clin Biochem
. 2022 Sep;
109-110:11-16.
PMID: 36113628
Objectives: Monoclonal gammopathy of undetermined significance (MGUS) patients with M-proteins containing n-glycosylated light chains (GLC) have an increased risk for progression to symptomatic plasma cell disorders (PCD). Large-scale research involving...
5.
Baloda V, Wheeler S, Murray D, Kohlhagen M, Vos J, Yatsenko S, et al.
Diagn Pathol
. 2022 Aug;
17(1):63.
PMID: 35932039
Background: Mu heavy chain disease is a rare lymphoid neoplasm characterized by vacuolated bone marrow plasma cells and secretion of defective mu immunoglobulin heavy chains. The biological basis of mu...
6.
Kanack A, Bayas A, George G, Abou-Ismail M, Singh B, Kohlhagen M, et al.
Blood
. 2022 May;
140(1):73-77.
PMID: 35560046
No abstract available.
7.
Dasari S, Kohlhagen M, Dispenzieri A, Willrich M, Snyder M, Kourelis T, et al.
Mayo Clin Proc
. 2021 Dec;
97(2):294-307.
PMID: 34887112
Objectives: To verify the analytical performance of a new mass spectrometry-based method, termed MASS-FIX, when screening for plasma cell disorders in a routine clinical laboratory. Patients And Methods: Results from...
8.
Fatica E, Martinez M, Ladwig P, Murray J, Kohlhagen M, Kyle R, et al.
Clin Biochem
. 2021 Aug;
97:67-73.
PMID: 34384797
Background: Plasma cell disorders (PCDs) are typically characterized by excessive production of a single immunoglobulin, defined as a monoclonal protein (M-protein). Some patients have more than one identifiable M-protein, termed...
9.
Mellors P, Kohlhagen M, Dasari S, Willrich M, Gertz M, Kumar S, et al.
Clin Chem Lab Med
. 2021 Jun;
59(11):e430-e433.
PMID: 34114387
No abstract available.
10.
Mellors P, Dasari S, Kohlhagen M, Kourelis T, Go R, Muchtar E, et al.
Blood Cancer J
. 2021 Jun;
11(6):110.
PMID: 34099625
No abstract available.